Correlation Between Hangzhou Arcvideo and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hangzhou Arcvideo and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hangzhou Arcvideo and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hangzhou Arcvideo Technology and Innovative Medical Management, you can compare the effects of market volatilities on Hangzhou Arcvideo and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hangzhou Arcvideo with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hangzhou Arcvideo and Innovative Medical.

Diversification Opportunities for Hangzhou Arcvideo and Innovative Medical

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hangzhou and Innovative is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Hangzhou Arcvideo Technology and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Hangzhou Arcvideo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hangzhou Arcvideo Technology are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Hangzhou Arcvideo i.e., Hangzhou Arcvideo and Innovative Medical go up and down completely randomly.

Pair Corralation between Hangzhou Arcvideo and Innovative Medical

Assuming the 90 days trading horizon Hangzhou Arcvideo Technology is expected to generate 1.4 times more return on investment than Innovative Medical. However, Hangzhou Arcvideo is 1.4 times more volatile than Innovative Medical Management. It trades about 0.03 of its potential returns per unit of risk. Innovative Medical Management is currently generating about 0.03 per unit of risk. If you would invest  2,571  in Hangzhou Arcvideo Technology on October 4, 2024 and sell it today you would earn a total of  136.00  from holding Hangzhou Arcvideo Technology or generate 5.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Hangzhou Arcvideo Technology  vs.  Innovative Medical Management

 Performance 
       Timeline  
Hangzhou Arcvideo 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hangzhou Arcvideo Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Innovative Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Hangzhou Arcvideo and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hangzhou Arcvideo and Innovative Medical

The main advantage of trading using opposite Hangzhou Arcvideo and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hangzhou Arcvideo position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Hangzhou Arcvideo Technology and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance